A Case of Percutaneous Intracavitary Amphotericin B Injection for the Treatment of Hemoptysis due to Pulmonary Aspergilloma

Amphotericin B의 경피적 공동내 주입술에 의한 폐국균종 치험 1예

Pulmonary Aspergillomas usually arise from proliferation of Aspergillus in preexisting parenchymal cavities.202 college students (99 men, 103 women) aged 18 to 26 years. Fasting blood samples were. The most common symptom in this disorder is hemoptysis, which may be minimal in amount or it may be massive & life threatening. The optimum therapy for pulmonary aspergilloma is controversial. The major options available include surgical resection of the lesion, a number of medical therapies, or simple observation of the patient for a time. Surgery is the most effective treatment but it is limited to some patient because most patients have underlying pulmonary disease. Thus the various form of medical therapy was available with successful result. The authors present a case of percutaneous intracavitary amphoterician B injection for the treatment of pulmonary aspergilloma & its successful effect for the repetitive hemoptysis.

저자들은 반복적인 객혈이 있는 폐국균종 환자에서 경피적 공동내 Amphotericin B의 주입에 의해 객혈에 대한 효과적인 치료 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.